Approvals/CIMA-AEMPS/REMSIMA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

REMSIMA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Celltrion Healthcare Hungary Kft.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 906f1e1a6d9eec88
Drug Cima Aemps Name: REMSIMA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 13853001IP1
Holder Company Name: Celltrion Healthcare Hungary Kft.
Marketing Company Name: Abacus Medicine A/S
Holder Company Detail Path: /organization/celltrion-healthcare-hungary-kft
Authorization Date: 2021-02-09
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 100 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Celltrion Healthcare Hungary Kft.
Company Detail Path: /organization/celltrion-healthcare-hungary-kft

INFLIXIMAB

100 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 9, 2021

Approval ID

906f1e1a6d9eec88

Type

Standard